| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.62 | 0.02 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.03 |